insights_auto
Why is VEEV up 2.12%?
Dive Deeperchevron_right
VEEV:NYSE
Veeva Systems Inc
$280.68
arrow_upward
+2.12%(+5.84) 1D
$281.10
arrow_upward
+0.15% (+0.42)bedtimeAfter hours
Closed: Sep 25, 4:00:06 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VEEV...
Open
$276.84
High
$282.81
Low
$275.91
Mkt. cap
45.44B
Avg. vol.
1.82M
Volume
1.74M
P/E ratio
45.90
52-wk high
$310.50
52-wk low
$148.05
EPS
$6.11
Beta
0.97
Shares outstanding
161.91M
No. of employees
8K
Open
$276.84
High
$282.81
Low
$275.91
Mkt. cap
45.44B
Avg. vol.
1.82M
Volume
1.74M
P/E ratio
45.90
52-wk high
$310.50
52-wk low
$148.05
EPS
$6.11
Beta
0.97
Shares outstanding
161.91M
No. of employees
8K
News stories
From web sources and news partners
Zacks
·
18 hours ago
Veeva Systems (VEEV) Outperforms Broader Market: What You Need to Know
Investing.com Canada
·
1 day ago
Form 4 Veeva Systems Inc Class A For: 25 September By Investing.com
Profile
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing.
The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Wikipedia
About Veeva Systems Inc
CEOPeter Gassner
Employees7.93K
Founded2007
HeadquartersPleasanton, California, United States
SectorHealth care
Websiteveeva.com